Sveriges mest populära poddar

TechCrunch Industry News

Nyheter Teknologi

Congratulations 23andMe users, your genes are finally helping the company make drugs

3 min•10 januari 2020

All of that genetic material that 23andMe has been collecting is finally being used for commercial drug development — specifically dermatological drugs. The company inked an agreement with Spanish pharmaceutical developer Almirall, which concentrates on medical dermatology treatments, for the development of dermatological treatments based on an antibody developed by 23andMe.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Fler avsnitt av TechCrunch Industry News

xAI burned $6.4B last year, the spending is far from over; plus, Jensen Huang says he’s found a ‘brand new’ $200B market for Nvidia

Elon Musk said Sam Altman ‘stole’ a non-profit — but the trial showed he had similar aims

Solar to dominate energy by 2035, but AI data centers will keep fossil fuels in business

The haves and have nots of the AI gold rush; Also, if you’re giving a commencement speech in 2026, maybe don’t mention AI

Even GoPro is pivoting to defense; plus, Elon Musk’s SpaceXAI has been bleeding staff since its merger

OpenAI is reportedly preparing legal action against Apple; it wouldn’t be the first partner to feel burned

Who decides what AI tells you? Campbell Brown, once Meta’s news chief, has thoughts; plus

Musk mulled handing OpenAI to his children; plus, Google and SpaceX in talks to put data centers into orbit

TikTok now wants to be the place you book the trip you just saw on TikTok; plus, AI is turning connected cars into pothole-finding machines

Cloudflare says AI made 1,100 jobs obsolete, even as revenue hit a record high; plus, Anthropic says ‘evil’ portrayals of AI can have real effect

TechCrunch Industry News med TechCrunch finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.